5’-O-DMTr-3’-deoxyuridine 2’-CED phosphoramidite
5’-O-DMTr-3’-deoxyuridine 2’-CED phosphoramidite is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Product Specifications
CAS Number
161503-98-6
UNSPSC
12352005
Hazard Statement
H302-H315-H319
Target
Nucleoside Antimetabolite/Analog
Type
Oligonucleotides
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/5-o-dmtr-3-deoxyuridine-2-ced-phosphoramidite.html
Solubility
10 mM in DMSO
Smiles
O=C(C=CN1[C@H]2[C@H](OP(N(C(C)C)C(C)C)OCCC#N)C[C@@H](COC(C3=CC=CC=C3)(C4=CC=C(OC)C=C4)C5=CC=C(OC)C=C5)O2)NC1=O
Molecular Formula
C39H47N4O8P
Molecular Weight
730.79
Precautions
P264-P270-P280-P302+P352-P305+P351+P338-P330-P362+P364-P501
References & Citations
[1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18 (23) :3373-88.
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
E-Cadherin / CD324 (Intercellular Junction Marker) (4A2), CF405M conjugate, 0.1mg/mL
P27 / KIP1 (SX53G8), CF594 conjugate, 0.1mg/mL
CD35 / CR1 (E11), CF740 conjugate, 0.1mg/mL
Ep-CAM / CD326 (VU-1D9), CF594 conjugate, 0.1mg/mL
